Fosun Pharma deepens global layout with new office in Jeddah, Saudi Arabia

The inauguration ceremony for the Fosun Pharma Middle East Office and Fosunhenlius Middle East United Company was recent...

October 1, 2025 | Wednesday | News
China's Fosun Pharma licenses DPP-1 inhibitor to Expedition Therapeutics for $645 M

China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...

August 12, 2025 | Tuesday | News
Israel's Moebius Medical & India's Sun Pharma receive fast track designation for osteoarthritis knee pain medicine

India-based Sun Pharma and Israel-based Moebius Medical have announced that the US Food and Drug Administration (FD...

September 6, 2024 | Friday | News
India's Sun Pharmaceuticals announces approval of Winlevi in Australia for acne treatment

India-based Sun Pharmaceutical Industries has announced that the Australian Therapeutic Goods Administration (TGA) has g...

March 20, 2024 | Wednesday | News
China's Fosun Pharma partners with IFC to improve access to high quality medicines in Africa

To support stronger healthcare delivery and outcomes in West Africa, Shanghai Fosun Pharmaceutical (Group) has...

June 7, 2023 | Wednesday | News
India's Sun Pharma inks new deal to commercialise skin cancer drug in Europe, Australia and New Zealand

India-based Sun Pharmaceutical Industries and Swiss-Italian biotech firm Philogen S.p.A have entered into a licensing ag...

May 31, 2023 | Wednesday | News
Neovii & Fosun Pharma ink agreement for bringing transplantation medicine to China

Neovii Pharmaceuticals, a Swiss based global specialty-care biopharmaceutical company, and Shanghai Fosun Pharmaceutical...

September 13, 2022 | Tuesday | News
Fosun Pharma, Amgen collaborate to bring two innovative medicines to Chinese patients

Fosun Pharma and Amgen have jointly announced a collaboration and license agreement for Fosun Pharma for the commerciali...

June 29, 2022 | Wednesday | News
VerImmune and Fosun Pharma focus on virus-inspired particle based novel immunotherapies in China

US-based  startup VerImmune and Fosun Pharma in China have entered into an exclusive license and option agreement. ...

May 23, 2022 | Monday | News
China-based Fosun Pharma and Insilico Medicine advance AI-driven drug discovery

Shanghai Fosun Pharmaceutical (Group) Co. and Insilico Medicine have entered into a collaboration agreement to advance t...

January 12, 2022 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls